DENTSPLY SIRONA XRAY NASDAQ · Healthcare · United States
$9.16 -0.87% -$0.08
Summary
40 / 100 · Bulios Score
What speaks for it
- The share price is below the Bulios Fair Price.
- It earns 13 USD a year on every 100 USD of invested capital.
What to watch
- The company made a loss over the last 12 months.
- Operating profit does not even cover the interest on its debt.
- Revenue fell by 2.1% a year over the last 3 years.
- It missed profit estimates 5 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBy our assumptions the business is worth more than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 2.0% a year over 5 years. Over the last 3 years it fell by 2.1% a year. For the next fiscal year analysts expect revenue to fall by 3.0%.
Growth in detailDoes it make money?
ReasonablyOver the last 12 months it made a loss of $121.0M.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 22.2 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Moderate, at risk- Yield
- 3.46%
You receive $0.32 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Neutral- Buy 12
- Hold 19
- Sell 1
Today's price within the analysts' price targets
The average target of $12.5 is 36% above today's price. 38% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2022By product
- Technologies And Equipment 59%
- Consumables Segment 41%
By region
- Europe 43%
- UNITED STATES 32%
- Other Foreign 25%
Technologies And Equipment brings in 59% of revenue.
Segments in detail